IPP Bureau
Kelun-Biotech and Crescent Biopharma forge strategic oncology partnership
By IPP Bureau - December 09, 2025
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
Viatris sells stake in Biocon Biologics for $815 million, regains global Biosimilars access
By IPP Bureau - December 09, 2025
Biocon will acquire all of Viatris’ convertible preferred equity in Biocon Biologics for $400 million in cash and $415 million in newly issued Biocon shares
Agilent and Monash Malaysia launch cutting-edge BioDiscovery hub to boost regional biotech
By IPP Bureau - December 09, 2025
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
AL-S Pharma shows promising Phase 2 results for its therapy in ALS treatment
By IPP Bureau - December 09, 2025
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
Covestro and Allmed Partner to pioneer recycling of artificial kidney filters
By IPP Bureau - December 09, 2025
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
Pharvaris’ deucrictibant shows rapid relief for hereditary angioedema in pivotal Phase 3 trial
By IPP Bureau - December 09, 2025
The study met its primary endpoint and all 11 secondary efficacy endpoints
Capricor's cell therapy shows breakthrough results in Duchenne muscular dystrophy trial
By IPP Bureau - December 09, 2025
It's a development that marks a potential breakthrough for people living with the rare and debilitating disease Duchenne muscular dystrophy (DMD)
Pfizer’s therapy scores major win in Phase 3 trial for Hemophilia patients with inhibitors
By IPP Bureau - December 08, 2025
HYMPAVZI’s safety profile was generally favorable
Halozyme wins German injunction blocking Merck’s Keytruda distribution
By IPP Bureau - December 08, 2025
While Merck can appeal, Halozyme said it expects the order to hold
Freenome strikes SPAC deal to go public in 2026
By IPP Bureau - December 08, 2025
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Bengaluru healthtech firm Biomoneta secures USFDA nod for air purifier
By IPP Bureau - December 08, 2025
Captured microbes are then neutralized on engineered microbicidal surfaces
New study aims to improve mobility for millions with flat foot and knee osteoarthritis
By IPP Bureau - December 08, 2025
The launch of the study was on the occasion of the International Day of Persons with Disabilities
Groundbreaking study identifies 250 genes driving ME & long COVID
By IPP Bureau - December 08, 2025
76 of 180 long COVID-associated genes also linked to ME
_Logo.png "Agilus Diagnostics launches comprehensive obesity & metabolic health test suite"){kind=logo}
Agilus Diagnostics launches comprehensive obesity & metabolic health test suite
By IPP Bureau - December 08, 2025
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
Praxis Precision hits milestone in fight against rare paediatric seizures
By IPP Bureau - December 08, 2025
The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies
